Amgen (AMGN) Revenue — Quarter Ended Dec 31, 2025
Revenue increased in the quarter, reaching a new high compared to the prior quarter. The gain also exceeded the year-ago period.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue increased in the quarter, reaching a new high compared to the prior quarter. The gain also exceeded the year-ago period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$9.9B
Revenue reported for this quarter.
Quarter-over-quarter
+3.2%
Change from the immediately preceding quarter.
Year-over-year
+8.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$36.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $8.1B | +9.4% |
| Jun 30, 2025 | $9.2B | +9.4% |
| Sep 30, 2025 | $9.6B | +12.4% |
| Dec 31, 2025 | $9.9B | +8.6% |
Revenue performance
The reported revenue reflects a sequential rise from the immediately preceding quarter, continuing the upward trend observed throughout the year.
Quarterly comparison
Compared to the same quarter one year earlier, revenue was also higher, extending the year-over-year growth pattern.
What to watch
The trailing twelve-month revenue has reached a substantial level, indicating sustained momentum.